BBIO vs MET-P-A

Comparison between BridgeBio Pharma Inc (BBIO, Company) and Metlife Inc (MET-P-A, Company).

5-Year PerformanceBBIO has outperformed MET-P-A, delivering a return of +3.0% compared to +2.9%

BBIO vs MET-P-A - Performance Comparison

Log

Key Characteristics

Financial metrics and valuation ratios

Metric	BBIO(COMPANY)	MET-P-A(COMPANY)
Market Cap	$14B	$14B
Max Drawdown	92.80%	33.29%
Sharpe Ratio	1.13	-0.93
5Y Beta	1.03	0.21
Industry	Biotechnology	N/A
P/E Ratio	-18.39	3.82
PEG Ratio	-3.28	N/A
5Y Dividends CAGR	N/A	9.40%
5Y EPS CAGR	-3.14%	29.35%
Debt to Equity	-116.44%	1.48%
Free Cash Flow Yield	-3.28%	N/A
P/S Ratio	23.42	N/A
P/B Ratio	123.68	N/A

Market Cap

BBIO

$14B

Winner

MET-P-A

$14B

Max Drawdown

BBIO

92.80%

Winner

MET-P-A

33.29%

Sharpe Ratio

Winner

BBIO

1.13

MET-P-A

-0.93

5Y Beta

BBIO

1.03

Winner

MET-P-A

0.21

Industry

BBIO

Biotechnology

MET-P-A

N/A

P/E Ratio

Winner

BBIO

-18.39

MET-P-A

3.82

PEG Ratio

BBIO

-3.28

MET-P-A

N/A

5Y Dividends CAGR

BBIO

N/A

MET-P-A

9.40%

5Y EPS CAGR

BBIO

-3.14%

Winner

MET-P-A

29.35%

Debt to Equity

Winner

BBIO

-116.44%

MET-P-A

1.48%

Free Cash Flow Yield

BBIO

-3.28%

MET-P-A

N/A

P/S Ratio

BBIO

23.42

MET-P-A

N/A

P/B Ratio

BBIO

123.68

MET-P-A

N/A

BBIO vs MET-P-A - Historical Returns

Returns include dividend reinvestment.

Period	BBIO	MET-P-A
1 month	+3.71%	-4.56%
3 months	-3.22%	+1.26%
6 months	-7.34%	+1.08%
1 year	+55.67%	-3.32%
5 years(CAGR)	+3.05%	+2.89%
10 years(CAGR)	N/A	+4.40%
Max(CAGR)	+14.31%	+4.89%

Winner

BBIO

+3.71%

MET-P-A

-4.56%

BBIO

-3.22%

Winner

MET-P-A

+1.26%

BBIO

-7.34%

Winner

MET-P-A

+1.08%

Winner

BBIO

+55.67%

MET-P-A

-3.32%

5Y(CAGR)

Winner

BBIO

+3.05%

MET-P-A

+2.89%

10Y(CAGR)

BBIO

N/A

MET-P-A

+4.40%

Max(CAGR)

Winner

BBIO

+14.31%

MET-P-A

+4.89%

BBIO vs MET-P-A - Annual Returns (2014 - 2026)

Returns include dividend reinvestment.

Year	BBIO	MET-P-A
2026	-10.22%	+1.18%
2025	+171.24%	-7.42%
2024	-32.16%	+17.75%
2023	+463.04%	+13.94%
2022	-55.59%	-9.51%
2021	-73.79%	+6.20%
2020	+114.06%	+6.92%
2019	+27.22%	+23.44%
2018	N/A	-10.67%
2017	N/A	+11.86%
2016	N/A	-2.66%
2015	N/A	+11.52%
2014	N/A	-2.75%

BBIO vs MET-P-A Drawdown Comparison

The maximum drawdown for BBIO was -92.80%, occurring on May 11, 2022. Recovery took 1211 trading sessions.

The maximum drawdown for MET-P-A was -31.44%, occurring on Mar 23, 2020. Recovery took 117 trading sessions.

The current BBIO drawdown is -12.10%. The current MET-P-A drawdown is -7.83%.

Rank	BBIO	MET-P-A
#1	-92.80% Feb 8, 2021 - Dec 3, 2025	-31.44% Mar 4, 2020 - Aug 19, 2020
#2	-65.45% Dec 23, 2019 - Nov 24, 2020	-20.61% Jul 10, 2018 - Jul 19, 2019
#3	-44.53% Sep 3, 2019 - Nov 20, 2019	-20.44% Aug 5, 2021 - Mar 8, 2023
#4	-21.99% Dec 31, 2020 - Feb 8, 2021	-10.87% Sep 29, 2025 - Mar 31, 2026
#5	-20.25% Jan 22, 2026 - Feb 5, 2026	-10.42% Feb 28, 2025 - Sep 29, 2025
#6	-16.79% Nov 22, 2019 - Dec 9, 2019	-9.21% Apr 24, 2023 - Sep 29, 2023
#7	-14.67% Jul 22, 2019 - Aug 26, 2019	-8.64% Oct 21, 2016 - Mar 22, 2017
#8	-12.87% Jul 11, 2019 - Jul 22, 2019	-7.91% Nov 27, 2015 - Mar 1, 2016
#9	-6.70% Dec 12, 2019 - Dec 18, 2019	-5.36% Oct 20, 2017 - Feb 27, 2018
#10	-6.15% Jan 2, 2026 - Jan 13, 2026	-5.21% Nov 26, 2014 - Feb 3, 2015
#11	-5.62% Jul 5, 2019 - Jul 11, 2019	-5.13% Jul 11, 2024 - Sep 5, 2024
#12	-5.28% Aug 27, 2019 - Sep 3, 2019	-4.41% Mar 8, 2023 - Mar 31, 2023
#13	-4.46% Dec 1, 2020 - Dec 4, 2020	-4.17% Jun 2, 2015 - Oct 22, 2015
#14	-4.45% Dec 18, 2019 - Dec 20, 2019	-4.04% Feb 20, 2020 - Mar 4, 2020
#15	-4.13% Dec 4, 2025 - Dec 12, 2025	-3.72% Sep 29, 2023 - Nov 3, 2023

Correlation

Correlation between BBIO and MET-P-A is 0.40 which considered as a weak positive correlation - the stocks show a slight tendency to move together.

0.40

-101